Oxidative stress has been implicated in the pathogenesis of various cardiovascular diseases, including ischemic heart disease and heart failure. The peroxisome proliferator-activated receptor gamma (PPAR) agonist improves insulin sensitivity and limits tissue inflammation and cellular apoptosis, but there are few data on the relationship between the PPAR agonist, rosiglitazone (RSG), and the thioredoxin (TRx) system in oxidatively stressed cardiomyocytes (CMCs). Here we provide evidence that the PPAR agonist RSG protects rat CMCs from hydrogen peroxide (H 2 O 2 )-induced apoptosis by TRx overexpression. The expression levels of pAkt/Akt, pErk/Erk, survivin, Bcl-2/Bax-, and manganese-superoxide dismutase were increased by RSG pretreatment in H 2 O 2 -injured rat CMCs. On the contrary, the expression levels of caspase-3 and p53 were decreased by RSG pretreatment. These effects of RSG were reversed by chemical inhibitors of TRx and the PPAR antagonist. This suggests that RSG protects rCMCs from H 2 O 2 -induced oxidative stress through TRx overexpression and a PPAR-dependent mechanism.
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In mammalian cardiac pathologies, oxidative stress originating from endogenously generated reactive oxygen species (ROS) is an important cause of cardiomyocyte (CMC) death. 1, 2) It can be increased by occlusion of the coronary artery in an ischemic heart, and it steeply aggravates within minutes of reperfusion. Hence reperfusion therapy is the best therapy for myocardial infarction and the typical secondary myocardial damage with oxidative stress in vivo. [3] [4] [5] Myocardial ischemia/ reperfusion can change the redox status of CMCs, and provoke CMC apoptosis or necrosis related to severe oxidative stress. 6) Thus certain interventions with ROS scavengers or antioxidants have been found to be cardioprotective against reperfusion injury in ischemic heart disease models. 7) The thioredoxin (TRx) system regulates the levels of intracellular ROS and modulates intracellular oxidationreduction statues. TRx is a ubiquitous 12-kDa protein that has disulfide reducing moieties. The two cysteine residues (Cys32 and Cys35) of the active site (-Cys-GlyPro-Cys-) serve as reducing agents. 8) Two isoforms of TRx have been discovered in mammalian cells. Each isoform has specific sites of action in the cells. TRx1 localizes within the cytosol and translocates to the nucleus during periods of oxidative stress. TRx2 resides exclusively in the mitochondria and affects mitochondrial redox homeostasis. 9) TRx has diverse protective biological functions in cells. It has not only cytoprotective function against oxidative stress, but also regulates cell survival signaling pathways. Clinical and experimental results have demonstrated that inhibition of TRx1 promotes apoptosis, especially under conditions of oxidative stress. 10) Recent in vitro studies have found that TRx1 action is inhibited by direct interaction between apoptosis signal-regulating kinase-1 and mitogen-activated protein (MAP), and that these reactions activate pro-apoptotic kinases such as p38 MAP kinase and c-Jun N-terminal kinase. 11) This suggests that TRx1 plays a critical role in regulating the balance between cell proliferation and cell death. 12) Peroxisome proliferator-activated receptors (PPARs) are ligand-activated transcription factors that belong to the nuclear receptor family which also includes hormone receptors, particularly steroid hormone receptors. 13) There are three subtypes of PPARs that are encoded by three distinct genes, designated PPAR-alpha, PPARdelta (as known as beta, PPAR/), and PPAR-gamma (PPAR). 14) PPARs regulate the metabolism of glucose and lipids by modulating gene expression by direct binding to target genes or by interfering with other cellular signaling pathways. They also influence inflammatory, fibrotic, and hypertrophic responses in the body. [15] [16] [17] They are expressed in several cell types in the cardiovascular system, including endothelial cells, vascular smooth muscle cells, and monocytes or macrophages in blood or tissues where they exert their antiy To whom correspondence should be addressed. Tel: +82-43-269-6011; Fax: +82-43-273-3252; E-mail: drcorazon@hanmail.net inflammatory, anti-fibrotic, anti-atherogenic, and cardiovascular protective effects. 15, 16, 18) Rosiglitazone (RSG), a PPAR agonist, is widely used in the control of diabetes. Recently, it was found that PPAR agonists protect CMCs from myocardial ischemia and reperfusion injury. 19) RSG also protects endothelial cells from glucose-induced oxidative stress through an AMPActivated Protein Kinase-dependent molecular pathway. 20) In addition, PPAR agonist reduces the fraction of neonatal rat CMCs (rCMCs) that undergo apoptosis under oxidative stress, through upregulation of Bcl-2 expression. 21) Given this background, we hypothesized that PPAR agonist RSG can reduce the apoptosis of rCMCs in the oxidative state created by H 2 O 2 , and that this protective action results from TRx overexpression. Here, we provide evidence that PPAR agonist RSG protects rCMCs from H 2 O 2 -induced apoptosis by upregulating TRx expression, suggesting that RSG is cardioprotective during ischemia-reperfusion injury.
Materials and Methods
Isolation and culture of neonatal rat cardiomyocytes. Isolation and primary culturing of rCMCs was performed by modification of previously reported protocols. 22, 23) All animal experiments were performed with the approval of the Institutional Review Board of the Chungbuk National University Laboratory Animal Research Center. 24) The band at the 1.062/1.082 density interface was collected and used source of rCMCs. The cells were washed and suspended in Dulbecco's Modified Eagle's Medium (DMEM, Gibco BRL, Rockville, MD) supplemented with Medium 199 (M199, Sigma-Aldrich, St. Louis, MO), 10% horse serum, 5% fetal bovine serum, 5,000 U/L of streptomycin, and 5,000 U/L of penicillin. The rCMCs were then plated at 5 Â 10 5 cells/well on 2% gelatincoated 60-mm Primaria plastic 6-well culture dishes (BD Sciences, San Jose, CA). Media changes were initially performed once daily with serum-free media containing DMEM:M199 (4:1). The rCMCs were cultured in 5% CO 2 at 37 C for 2-3 d before exposure to experimental conditions. Generation of oxidative stress by H 2 O 2 . The raw chemical of RSG was supplied by GlaxoSmithKline (Brentford, London, UK). The rCMCs were exposed to 1 mM of RSG for 1 h, and then exposed to 0.5 mM H 2 O 2 for 4 h in the presence of RSG. Another two groups of rCMCs were pretreated with 10 mM of PX 12 (1-methylpropyl-2-imidazolyl disulfide, a specific chemical inhibitor of TRx, Tocris Bioscience, Bristol, UK), or 10 mM of GW 9662 (2-chloro-5-nitrobenzanilide, a specific PPAR antagonist, Cayman, Ann Arbor, MI) for 16 h, and then RSG was added.
Quantification of apoptosis by fluorescence-activated cell sorting. Cultured rCMCs were processed using Annexin V: Phycoerythrin (PE) Apoptosis Detection Kit I (BD Sciences) to assess cell membrane integrity. 7-Aminoactinomycin D (7-AAD) (BD Sciences) was used as marker of dead or dying cells. The technique is based on an assessment of cell membrane permeability and on the intercalation of doublestranded DNA. In brief, the rCMCs collected were washed twice with cold phosphate buffered saline and then resuspended in 1X binding buffer (10 mM HEPES, 140 mM NaCl, 2.5 mM CaCl 2 , pH 7.4) at a concentration of 1 Â 10 5 cells/mL. The mixture was then transferred to a culture tube, and 5 mL of Annexin-V and 5 mL of 7-AAD were added.
After gentle vortexing, the cell line was incubated for 10 min at room temperature in a dark environment, and was analyzed using a FACS instrument (FACS Calibur-S, BD Sciences) equipped with an argon ion laser system at excitation and emission wavelengths of 488 and 578 nm respectively.
Western blot analysis. We examined the expression pattern of the TRx system in rCMCs stressed by H 2 O 2 , Western blotting was performed on samples at baseline and at 4 h after the addition of 0.5 mM of H 2 O 2 , as follows: Harvested rCMCs were immersed in PRO-PREP Protein Extraction Solution (iNtRON Biotechnology, Seongnam, Korea) and incubated at À20
C for 12 h. The extracts were centrifuged at 4 C for 15 min at 12,000 rpm to remove insoluble material. The Bradford assay was used to quantify protein expression. 25) Protein concentrations were measured using a dye-binding assay (Bio-Rad Protein Assay Kit, Bio-Rad Laboratories, Hercules, CA). Equal amounts of total protein (25 mg) were diluted with sample buffer containing 100 mM dithiothreitol and heated to 95 C for 5 min, then subjected to 10-15% sodium dodecyl sulfate-polyacrylamide gel electrophoresis in a gel apparatus (Hoefer Scientific, San Francisco, CA), and then transferred to polyvinylidene fluoride membranes. Blots were blocked with 5% skim milk in Tris-buffered Saline Tween-20 (TBST) for 2 h and then incubated at 1:2,000 in TBST, with shaking at room temperature for 1 h, with antibodies against TRx (AbFRONTIER, Seoul, Korea), manganese-superoxide dismutase (Mn-SOD), TxNip, Akt, pAkt, Erk, pErk, Bcl-2, Bax, caspase-3, p53, and survivin (Santa Cruz Biotechnology, Santa Cruz, CA). The membranes were then washed with TBST, incubated with horseradish peroxidase-conjugated secondary antibody (1:5,000-1:10,000) for 1 h, and treated with West-Zol kits (iNtRON Biotechnology) for 1 min. Chemiluminescence was detected using an LAS-3000 imaging system (Fujifilm, Tokyo) for 10-300 s. Optical densities (OD) were calculated using the MultiGauge v.3.1 program (Fujifilm, Tokyo). The experiments were repeated 5 times, and the results were expressed as means AE SD of the OD, as percentages of the baseline values. Percentage changes in OD versus baseline were also calculated with respect to time.
Real-time RT-PCR analysis. Total ribonucleic acid (RNA) was extracted from the cultured cells using TRIzol Reagent (Invitrogen, San Diego, CA) following the manufacturer's instructions. Real-time polymerase chain reaction (PCR) was performed by using a Qiagen QuantiTect SYBR Green PCR Kit (Qiagen, Hilden, Germany) and a 7500 Realtime PCR System (Applied Biosystems, Foster, CA). Genespecific primers for the rat TRx gene (forward, 5 0 -TCC AAT GTG GTG TTC CTT GA-3 0 ; reverse, 5 0 -ATA GAA CTG GAA GGT CGG CA-3 0 ) and the rat glyceraldehyde-3-phosphate dehydrogenase (GAPDH) gene (forward, 5 0 -GTG AAG GTC GGT GTG AAC G-3 0 ; reverse, 5 0 -GGT TCA CAC CCA TCA CAA AC-3 0 ) were synthesized (Bioneer, Daejeon, Korea). A master mix was prepared containing 10 mL of QuantiTect SYBR Green PCR master mix, 7 mL of RNAsefree water, and 0.5 mL of forward and reverse primers (20 pM) per reaction. 18 mL of this master mix was added to 2 mL of cDNA inside LightCycler capillaries (Roche, Indianapolis, IN). The real-time PCR conditions were as follows: 20 min at 50 C (stage 1, carryover prevention), 15 min at 95 C (stage 2, PCR initial activation), and then 42 cycles of amplification for 30 s at 94 C, 30 s at 58 C, and 30 s at 72 C (stage 3, PCR). We performed a melting curve analysis of the real-time PCR products. TRx mRNA expression was evaluated.
Statistical analysis. Each experiment was performed independently a minimum of 3 times in cell culture, or as otherwise stated in the figure legends. Results were expressed as mean AE SD. Statistical analysis was performed by Student's two-tailed t-test using SPSS v. 16 .0 (SPSS, Chicago, IL). Differences were considered statistically significant at p < 0:05.
Results

RSG increased the expression of TRx mRNA
Prior to the main experiment, we confirmed that the degrees of H 2 O 2 -induced significant oxidative stress and RSG protected rCMCs from apoptosis associated with H 2 O 2 -induced oxidative stress RSG effectively reduced the fraction of rCMCs that underwent apoptosis induced by H 2 O 2 , as compared to the rCMCs exposed to H 2 O 2 without RSG treatment (Fig. 3, 1 :39 AE 0:20 vs. 3:69 AE 0:44, p < 0:05). In addition, to exploit the mechanisms underlying the reduction in apoptosis by RSG in H 2 O 2 -induced oxidative stress, we examined two molecular pathways activated by TRx and PPAR. We used PX 12 to limit the anti-oxidative activity of TRx and GW 9662 to block the effects of PPAR agonist RSG. PX 12 and GW 9662 increased the apoptotic fraction of rCMCs in H 2 O 2 (Fig. 3 0:21%, p < 0:05, Fig. 5 ). Overexpression of Mn-SOD and survivin due to RSG treatment on H 2 O 2 injured rCMCs was significantly reversed by PX 12 and by GW 9662 (Supplemental Fig. 2 ).
Discussion
There were two major findings in this study. First, RSG attenuated H 2 O 2 -induced apoptosis in rCMCs. Second, the antiapoptotic effects of RSG on oxidatively stressed rCMCs were transmitted through TRx and PPAR-dependent pathways.
PPARs are ligand-binding transcription factors belonging to the nuclear receptor superfamily, which also includes receptors for steroids, thyroid hormone, and retinoids.
21) The functions of PPARs are diverse, including regulation of lipid metabolism, immune function, cell growth, cell differentiation, and apoptosis. 26) PPARs are involved in the pathomechanisms of several diseases, including obesity, diabetes, cardiovascular disease, and malignancy. 27) In recent years, the significance of PPARs as therapeutic targets in cardiovascular disease has been recognized. RSG is a synthetic PPAR ligand that was developed as an insulin-sensitizing agent to control diabetes mellitus. Besides glucose control, RSG shows diverse therapeutic effects in the regulation of endothelial function, cellular apoptosis, tissue fibrosis, and the control of blood pressure. [28] [29] [30] [31] [32] In addition, it limits cardiac hypertrophy in diet-induced hypercholesterolemic rats by the renin-angiotensin system. 16) Furthermore, current evidence suggests that it has beneficial effects on CMCs under oxidative stress. For example, it decreases rCMC apoptosis in a hypoxia/ re-oxygenation model by enhanced Akt re-phosphorylation and in oxidative stress through a Bcl-2-dependent pathway. 19, 21) Our study suggests that RSG has a cardioprotective effect in limiting the apoptosis of CMCs during the excessive oxidative stimulation that can be generated by ischemia-reperfusion. 28) TRx is a small, ubiquitous, thiol protein that is one of the important regulators of the reduction-oxidation balance and redox-controlled cell functions. The regulation of TRx is closely related to control of the cellular redox balance, the promotion of cell growth, inhibition of apoptosis, and modulation of inflammation. The redox activity of TRx depends entirely on two cysteine residues, Cys32 and Cys35. 33) These residues exist as a dithiol in reduced form and a disulfide in oxidized form. TRx is oxidized when it transfers reducing equivalents to disulfide groups in target proteins, and reduced back to the dithiol form by an NAD(P)H-dependent protein, TRx reductase. 34) Moreover, it is markedly expressed in rCMCs and protects them from oxidative stress. 35, 36) In this study, we found that RSG significantly decreased H 2 O 2 -induced oxidative stress, and this effect was dependent on its ability to activate PPAR. Our data also suggest that most of the antioxidative activity of RSG is determined by its ability to activate TRx. This was confirmed by the reversal of the anti-apoptotic effect of RSG in H 2 O 2 -induced oxidative stress treatment by PX 12, a specific chemical inhibitor of TRx (Figs. 3 and 4) . The gross antioxidative effects of TRx depend mainly on the expression and balance of TRx and TxNip in the TRx system. 37) TxNip is an endogenous inhibitor of TRx that binds to the redox-specific active site of TRx, thereby negatively regulating TRx activity. TxNip is believed to be strongly induced by oxidative stress. 14) In this study TxNip expression in RSG groups decreased more than in the H 2 O 2 group. These results suggest that RSG regulated the expression of TRx and TxNip in the TRx system, but PX 12 decreased the expression of TxNip more than the other chemical groups. This finding may have been caused by a feedback mechanism involving transient increases of oxidative stress related to intracellular TRx reduction by PX 12 (Fig. 4) . TRx also induces gene expression of another anti-oxidant, Mn-SOD. Mn-SOD is an enzyme that catalyzes superoxide into H 2 O 2 , and it is present in almost all cells exposed to oxygen. 38) In our results, Mn-SOD was significantly raised in the rCMCs of the RSGtreated groups as compared control and the H 2 O 2 group (Fig. 5) . These results suggest that treatment by RSG increased anti-oxidant enzymes and improved the survival of rCMCs under oxidative stress.
The PI3K/Akt pathway is crucial for the cell survival mechanism that attenuates apoptosis and regulates glycogen synthesis and glucose transport. Phosphorylation and activation of Akt limits ischemia/reperfusion 12) Furthermore, our experiments also indicate that H 2 O 2 induced significant levels of apoptosis in cultured rCMCs, and that RSG effectively attenuated this process through overexpression of the TRx protein (Fig. 4) . Additionally, we found that the ability of RSG to attenuate oxidative stress was mediated through activation of Akt and its effector proteins. Our results thus suggest that RSG treatment can limit H 2 O 2 -induced oxidative stress in rCMCs.
In conclusion, TRx and PPAR are closely associated in protecting rCMCs from the apoptosis induced by oxidative stress. Targeting of TRx through the PPAR agonist RSG might constitute a new strategy to limit secondary myocardial damage related to reperfused oxidative stress in acute myocardial infarction treatment.
